The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of lenalidomide in diffuse large B-cell (DLBCL) and high-grade NHL (HGBCL): A single-center retrospective analysis.
 
Thomas David Rodgers
No Relationships to Disclose
 
Andrea M Baran
No Relationships to Disclose
 
Patrick Michael Reagan
Research Funding - Seagen
 
Carla Casulo
Honoraria - Gilead Sciences
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Andrew Evans
No Relationships to Disclose
 
Walter Richard Burack
No Relationships to Disclose
 
Jonathan W. Friedberg
Consulting or Advisory Role - Astellas Pharma; Bayer
Research Funding - Kite, a Gilead company (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
Travel, Accommodations, Expenses - Roche
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Janssen; Merck; Novartis; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - Pharmacyclics (Inst)